Serum and lung levels of thiamphenicol after administration of its glycinate N-acetylcysteinate ester in experimentally infected guinea pigs

International Journal of Antimicrobial Agents

Volumn 13, Issue 4, 2000, Pages 301-303

  Drago, Lorenzo ^a   De Vecchi, Elena ^a   Fassina, Maria Cristina ^a   Mombelli, Barbara ^a   Gismondo, Maria Rita ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Guinea pigs; N acetylcysteine; Thiamphenicol

Indexed keywords

ACETYLCYSTEINE; THIAMPHENICOL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GUINEA PIG; HAEMOPHILUS INFLUENZAE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LUNG PARENCHYMA; NONHUMAN; PRIORITY JOURNAL;

ACETYLCYSTEINE; ANIMALS; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; DRUG COMBINATIONS; FEMALE; GUINEA PIGS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; INJECTIONS, SUBCUTANEOUS; LUNG; THIAMPHENICOL;

EID: 0033960360     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00130-2     Document Type: Article

References (14)

1. Becker D., Katz J., Metz J. Comparative effects of thiamphenicol and chloramphenicol on haemopoiesis and lymphocyte transformation in vitro in man. Postgrad. Med. J. 50(Suppl 5):1974;88-94.
2. Lageze M.M.P., Paramelle B., Piediminote L. Interet du thiophenicol dans le traitement des bronchopneumopathies chroniques. Lyon Med. 213:1965;365-378.
3. Carlone N.A., Cuffini A.M., Marca G., Nicolino M.L. Indagini in vitro sull'attuale attività del tiamfenicolo nei confronti di ceppi batterici di primo isolamento. G. Batt. Virol. Immunol. 74:1981;275-282.
4. Abdennebi E.H., Sawchuk R.J., Stowe C.M. Thiamphenicol pharmacokinetics in beef and dairy cattle. J. Vet. Pharmacol. Ther. 17:1994;365-368.
5. Marca G., Albini E. Osservazioni sull'attività antibatterica del tiamfenicolo glicinato acetilcisteinato. Quad. Sclavo. Diagn. 15(Suppl 1):1975;777-784.
6. Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee. Thorax. 40:1985;832-835.
7. Syriopoulou V.P., Harding A., Goldmann A., Smith A.L. In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob. Agents Chemother. 19:1981;294-297.
8. De Craene BA, Deprez P, d'Haese E, Nelis HJ, Van den Bossche, De Leenheer AP. Pharmacokinetics of florfenicol in cerebrospinal fluid and plasma of calves, Antimicrob Agents Chemother 1997;41:1991-5.
9. Neu H.C., Fu P.K. In vitro activity of chloramphenicol and thiamphenicol analogs. Antimicrob. Agents Chemother. 18:1980;311-316.
10. Pennington J.E. Penetration of antibiotics into respiratory secretions. Rev. Infect. Dis. 3:1981;67-73.
11. Riise G.C., Larsson S., Larsson P., Jeanssons S., Andersson B.A. The intrabronchial microbial flora in chronic bronchitis patients: a target for N-acetylcysteine therapy? Eur. Respir. J. 7:1994;94-101.
12. Olivieri D., Marsico S.A., Del Donno M. Improvement of mucociliary transport in smokers by mucolytics. Eur. J. Respir. Dis. (Suppl). 66:1985;142-145.
13. Albini E, Arena E, Belluco G, Schioppacassi G, Ungheri D. Activity of aerosol thiamphenicol glycinate acetylcysteinate in a mouse model of S. pyogenes pneumonia, Arzneim Forsch Drug Res (in press).
14. Thiamphenicol. Experimental and Clinical Bases of a New Antibiotic. 1968;Zambon, Bresso.